Free shipping on all orders over $ 500

Rigosertib (free base)

Cat. No. M13719

All AbMole products are for research use only, cannot be used for human consumption.

Rigosertib (free base) Structure
Synonym:

ON-01910

Size Price Availability Quantity
5mg USD 70  USD70 In stock
10mg USD 120  USD120 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Rigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. Rigosertib is a selective and non-ATP-competitive inhibitor of PLK1 with an IC50 of 9 nM.

*The compound is unstable in solutions, freshly prepared is recommended



Chemical Information
Molecular Weight 451.49
CAS Number 592542-59-1
Solubility (25°C) DMSO 75 mg/mL
Storage -20°C, sealed
References

[1] Katarzyna Radke, et al. Transl Oncol. Anti-tumor effects of rigosertib in high-risk neuroblastoma

[2] Yin Wang, et al. Immun Inflamm Dis. Rigosertib inhibits MEK1-ERK pathway and alleviates lipopolysaccharide-induced sepsis

[3] Joshua T Kowalczyk, et al. Mol Cancer Ther. Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

[4] Marco Jost, et al. Mol Cell. Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing Agent

[5] Marco Jost, et al. Mol Cell. Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent

Related PLK Products
(1E)-CFI-400437 dihydrochloride 

(1E)-CFI-400437 dihydrochloride is a potent PLK4 (IC50= 0.6 nM) inhibitor and selective against other members of the PLK family (>10 μM).

3MB-PP1

3MB-PP1 is a bulky purine analog and inhibitor of Polo-like kinase 1 (Plk1) that blocks mitotic progression and cytokinesis by targeting Plk1 in cells expressing the analog-sensitive Plk1 allele. 3MB-PP1 also specifically inhibits the activity of Leu93 mutant Zipper-interacting Ssn3 (Cdk8). 3MB-PP1 inhibits the activity of Leu93 mutant Zipper-interacting Ssn3 (Cdk8). In addition, 3MB-PP1 specifically inhibits the activity of analog-sensitive Ssn3 (Cdk8). 3MB-PP1 inhibits the Leu93 mutant Zipper-interacting protein kinase (Leu93-ZIPK; IC50=2 μM). 3MB-PP1 can be used in the mycelium of Candida albicans. 3MB-PP1 can be used in studies related to mycelium formation and cell division in Candida albicans.

CYC-800

CYC-800 is a PLK1 inhibitor that can be used in tumor-related studies.

SOL-686

SOL-686 is a PLK1 inhibitor that can be used in glioma-related studies.

BAL0891

BAL0891 is a potential first-in-class PLK1/TTK inhibitor with antiproliferative activity for studies related to solid tumors.

  Catalog
Abmole Inhibitor Catalog




Keywords: Rigosertib (free base), ON-01910 supplier, PLK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.